Meiou Dai

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer.

In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer.

Journal: Nature communications

Published: November 05, 2025

Identification of HSPE1 as a new actionable cancer vulnerability leads to an innovative and effective combination therapy for pancreatic ductal adenocarcinoma.

Identification of HSPE1 as a new actionable cancer vulnerability leads to an innovative and effective combination therapy for pancreatic ductal adenocarcinoma.

Journal: Molecular cancer

Published: July 02, 2025

Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes.

Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes.

Journal: NPJ precision oncology

Published: February 27, 2024

Correction: Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation.

Correction: Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation.

Journal: The Journal of biological chemistry

Published: October 09, 2023

Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer.

Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer.

Journal: Molecular cancer

Published: September 08, 2023

Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance.

Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance.

Journal: Oncogenesis

Published: March 28, 2023

TGFβ/cyclin D1/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity.

TGFβ/cyclin D1/Smad-mediated inhibition of BMP4 promotes breast cancer stem cell self-renewal activity.

Journal: Oncogenesis

Published: November 01, 2020

Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis.

Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis.

Journal: Oncogenesis

Published: July 27, 2020

Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways.

Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways.

Journal: Cancer research

Published: June 22, 2020

In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy.

In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy.

Journal: Nature communications

Published: May 14, 2020

Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells.

Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells.

Journal: British journal of cancer

Published: May 03, 2018

Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.

Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: January 12, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026